4.7 Article

How will mass-vaccination change COVID-19 lockdown requirements in Australia?

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

Oxford-AstraZeneca COVID-19 vaccine efficacy

Maria Deloria Knoll et al.

LANCET (2021)

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Editorial Material Infectious Diseases

The role of schools and school-aged children in SARS-CoV-2 transmission

Stefan Flasche et al.

LANCET INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

Article Medicine, General & Internal

Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster

Ivan F N Hung et al.

LANCET (2021)

Editorial Material Medicine, General & Internal

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Ester C. Sabino et al.

LANCET (2021)

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

Article Multidisciplinary Sciences

Risk mapping for COVID-19 outbreaks in Australia using mobility data

Cameron Zachreson et al.

Summary: COVID-19 is highly transmissible, requiring rapid and effective responses. Research shows that human mobility data can estimate geographical transmission risk, especially in outbreaks involving workplaces or habitual travel patterns.

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2021)

Article Multidisciplinary Sciences

Interfering with influenza: nonlinear coupling of reactive and static mitigation strategies

Cameron Zachreson et al.

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2020)

Article Multidisciplinary Sciences

Virological assessment of hospitalized patients with COVID-2019

Roman Woelfel et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

Joseph T. Wu et al.

NATURE MEDICINE (2020)

Article Public, Environmental & Occupational Health

Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention

Sarah M. Bartsch et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling

Rebecca J. Rockett et al.

NATURE MEDICINE (2020)

Article Mathematics, Interdisciplinary Applications

Impact of network assortativity on epidemic and vaccination behaviour

Sheryl L. Chang et al.

CHAOS SOLITONS & FRACTALS (2020)

Article Multidisciplinary Sciences

Modelling transmission and control of the COVID-19 pandemic in Australia

Sheryl L. Chang et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Creating a surrogate commuter network from Australian Bureau of Statistics census data

Kristopher M. Fair et al.

SCIENTIFIC DATA (2019)

Article Computer Science, Interdisciplinary Applications

Investigating spatiotemporal dynamics and synchrony of influenza epidemics in Australia: An agent-based modelling approach

Oliver M. Cliff et al.

SIMULATION MODELLING PRACTICE AND THEORY (2018)

Article Multidisciplinary Sciences

Sensitivity Analysis of an Individual-Based Model for Simulation of Influenza Epidemics

Elaine O. Nsoesie et al.

PLOS ONE (2012)

Article Multidisciplinary Sciences

The effect of opinion clustering on disease outbreaks

Marcel Salathe et al.

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2008)

Article Multidisciplinary Sciences

Mitigation strategies for pandemic influenza in the United States

TC Germann et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)